Substance / Medication

Glutaraldehyde

Overview

Active Ingredient
glutaral
RxNorm CUI
4888

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Glutaraldehyde, Chlorhexidine, and Peracetic Acid are Preferred Disinfectants for Repeated or Prolonged Disinfection of Denture Base Resins.
Komlenic Vojislav, Puzovic Katarina, Beljic-Ivanovic Katarina et al. · J Evid Based Dent Pract · 2025
PMID: 41290280Meta-Analysis
Glutaraldehyde-based desensitizer does not influence postoperative sensitivity and clinical performance of posterior restorations: A 24-month randomized clinical trial.
Hanzen Taíse Alessandra, de Paula Alexandra Mara, Grokoski Eduardo et al. · Dent Mater · 2023
PMID: 37648563RCT
Postoperative sensitivity in posterior resin composite restorations with prior application of a glutaraldehyde-based desensitizing solution: A randomized clinical trial.
de Oliveira Isabelle Lins Macêdo, Hanzen Taíse Alessandra, de Paula Alexandra Mara et al. · J Dent · 2022
PMID: 34879245RCT
Comparison of fresh and glutaraldehyde-treated autologous pericardial patch in tricuspid valve repair: A long-term porcine study.
Zhang Xiaoya, Zhang Mingkui, Jin Yongqiang et al. · J Thorac Cardiovasc Surg · 2025
PMID: 40324746Observational
Safety of immunotherapy withglutaraldehyde-polymerized allergen extract in adults and children.
Caballero Raquel, Javaloyes Gracia, Romero Marta et al. · Allergol Immunopathol (Madr) · 2024
PMID: 39515790Observational
Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position.
Neufang Achim, Duenschede Fritz, Espinola-Klein Christine et al. · J Vasc Surg · 2020
PMID: 31870757Observational
Immobilization of β-glucosidase by self-catalysis and compared to crosslinking with glutaraldehyde.
Naseer Sidra, Ouyang Jie, Chen Xing et al. · Int J Biol Macromol · 2020
PMID: 31733256Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Glutaraldehyde (substance)
SNOMED CT
22242006
UMLS CUI
C0017814
RxNorm CUI
4888

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.